NOCDURNA

This brand name is authorized in Canada, Finland, Hong Kong SAR China, Israel, Netherlands, Romania, Singapore.

Active ingredients

The drug NOCDURNA contains one active pharmaceutical ingredient (API):

1	Desmopressin UNII XB13HYU18U - DESMOPRESSIN ACETATE
	Desmopressin is a structural analogue of vasopressin in which the antidiuretic activity has been enhanced by the order of 10, while the vasopressor effect has been reduced by the order of 1500. The clinical advantage of this highly changed ratio of antidiuretic to vasopressor effect is that clinically active antidiuretic doses are far below the threshold for a vasopressor effect.
	Read more about Desmopressin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NOCDURNA Orally disintegrating tablet	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01BA02	Desmopressin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BA Vasopressin and analogues
Discover more medicines within H01BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02397927, 02431076
FI	Lääkealan turvallisuus- ja kehittämiskeskus	198665, 580699
HK	Department of Health Drug Office	65128, 65129
IL	מִשְׂרַד הַבְּרִיאוּת	8707, 8708
NL	Z-Index G-Standaard, PRK	134651, 134678
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62974001, W62974002, W62974003, W62974004, W62975001, W62975002, W62975003, W62975004
SG	Health Sciences Authority	15461P, 15462P
US	FDA, National Drug Code	55566-5050, 55566-5070